Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FXND7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,825
Award facts
- Contract value 100% obligated
- $10,825.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,825.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 mL pens on September 26, 2025, with completion expected by September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Wegovy—a diabetes and weight management medication—aligns with AmerisourceBergen's established capability to fulfill federal medical supply needs through the Defense Health Agency and other government healthcare systems. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among key strategic pharmaceutical suppliers supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FXND7?
SPE2DB25FXND7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXND7 worth?
The government has obligated $10,825 on SPE2DB25FXND7.
Is contract SPE2DB25FXND7 an order under another contract?
Yes. SPE2DB25FXND7 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXND7 competed?
The extent of competition for SPE2DB25FXND7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award